Curis Lifesciences Ltd. IPO Details – Price, Date, GMP & Analysis
Curis Lifesciences Ltd. IPO Overview
Company Overview
Curis Lifesciences Limited, established in 2010, is a pharmaceutical company focused on developing, manufacturing, and distributing a wide range of products. It operates a modern manufacturing facility in Sanand, Gujarat, ensuring high-quality standards. The company serves over 100 corporate clients through contract manufacturing and has its own brand marketing in Yemen and Kenya. It offers various pharmaceutical formulations, including tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, Curis Lifesciences employs 93 permanent staff.
IPO Timeline
Opens
Nov 7
Closes
Nov 11
Allotment
Nov 12
Refunds
Nov 13
Shares Credit
Nov 13
Listing
Nov 14
Opens
Nov 7
Closes
Nov 11
Allotment
Nov 12
Refunds
Nov 13
Shares Credit
Nov 13
Listing
Nov 14
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 96.17x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 115.46x | Oversubscribed |
| RII (Retail Individual Investors) | 44.28x | Oversubscribed |
| Total Subscription | 74.39x | Oversubscribed |
Last updated: Nov 11, 2025, 06:21 PM
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ₹42.53 Cr | ₹42.53 Cr | ₹33.88 Cr | ₹29.75 Cr |
| EBITDA | ₹9.54 Cr | ₹9.54 Cr | ₹8.39 Cr | ₹3.28 Cr |
| NET Worth | ₹16.23 Cr | ₹16.23 Cr | ₹5.87 Cr | ₹1.01 Cr |
| Profit After Tax | ₹6.11 Cr | ₹6.11 Cr | ₹4.87 Cr | ₹1.88 Cr |
| Reserves and Surplus | ₹10.29 Cr | ₹10.29 Cr | ₹5.37 Cr | ₹0.51 Cr |
| Total Borrowing | ₹15.62 Cr | ₹15.62 Cr | ₹17.09 Cr | ₹16.19 Cr |
| Total Income | ₹49.65 Cr | ₹49.65 Cr | ₹35.87 Cr | ₹36.42 Cr |
Strengths & Risks Analysis
Key Risks
Potential challenges and risk factors
- High dependence on third-party manufacturers for product quality and timelines.
- Intense competition from established apparel brands and fast-fashion players.
- Reliance on India’s discretionary spending trends and vulnerable to economic slowdown.
- No long-term contracts with suppliers and distributors may disrupt supply chains.
IPO Details
Curis Lifesciences IPO Details
| Face Value | ₹10 per share |
| IPO Date | November 7, 2025 to November 11, 2025 |
| Issue Price Band | ₹120 to ₹128 per share |
| Issue Price Final | ₹128 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Listing Date | November 14, 2025 |
| Lot Size | 1,000 Shares |
| Net Offered to Public | 20,42,000 shares (aggregating up to ₹26.14 Cr) |
| Reserved for Market Maker | 1,08,000 shares (aggregating up to ₹1.38 Cr)RS Wealth Management Private Limited |
| Sale Type | Fresh Capital |
| Share Holding Post Issue | 80,84,434 shares |
| Share Holding Pre Issue | 59,34,434 shares |
| Total Issue Size | 21,50,000 shares (aggregating up to ₹27.52 Cr) |
Curis Lifesciences IPO Reservation
Share Reservation Distribution
Curis Lifesciences IPO Promoter Holding
| Promoter Holding Post Issue | 68.03% |
| Promoter Holding Pre Issue | 92.68% |
Curis Lifesciences IPO Listing Details
| BSE Script Code | |
| Final Issue Price | ₹128 per share |
| ISIN | INE1BZN01016 |
| Listing Date | November 14, 2025 |
| NSE Listing Group | ST (Trade to Trade) |
| NSE Symbol | CURIS |
Key Dates
